TRIPLE-1/FUJITSU
18.3.2019 16:02:06 CET | Business Wire | Press release
TRIPLE-1, Inc. (Representative Director: Takuya Yamaguchi) and Fujitsu Electronics Inc. (Representative Director: Junji Ogihara) have entered into a distributorship contract for a mining ASIC (application specific IC) “KAMIKAZE” that uses the world's most advanced 7nm process technology.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190318005034/en/
--- Background:
In the development market for mining ICs, which requires huge computing power and high power efficiency, the introduction of advanced process technology has been attempted positively and just like the development market for ICs for smartphones, which is one of the world's leading manufacture industries, the driving force for development came from the process miniaturization in the advanced semiconductor industry. As of 2019, there is a mover away from the mainstream 16nm process which had been the oligopoly of traditional Chinese region manufacturers to the state-of-the-art 7nm process. In the past, several companies, including Japanese companies, announced their entry into cutting-edge 7nm process development, but at the moment there are only a handful of manufacturers that have succeeded in commercializing ASIC (application specific IC).
--- Purpose / Perspective:
TRIPLE-1 is a semiconductor system development company established in
November 2016 and specializing in cutting-edge process technology.
Since
February 2017, we began to develop the ASIC (application specific IC)
"KAMIKAZE" for bitcoin mining adopting the world's most advanced 7nm
process technology.
About a year later in February 2018, we
announced the world's first tape-out (design completion) in the
state-of-the-art 7nm process for the same application and proceeded with
commercialization by TSMC (Taiwan), the world's largest foundry.
Currently
TRIPLE-1 is the only manufacturer of ASIC (application specific IC) that
adopts the state-of-the-art 7nm process technology in Japan and is the
only Japanese company that confronts the world in the cutting-edge
process development market.
Fujitsu Electronics develops a wide
range of products from various brands and manufacturers for markets
around the world by making full use of the global network spreading both
in Japan and abroad, centered on the "Fujitsu brand" that has continued
to be trusted for many years around the world.
Through the signing
of this distributorship contract, we will be able to spread the global
development potential of Fujitsu Electronics and the state-of-the-art
process development capabilities of TRIPLE-1 all over the world and
provide the real value of “Japanese manufacturing” to markets around the
world. On top of that, by establishing a long-term and strong
partnership, we will cooperate not only in mining ASIC (application
specific IC), but also in the development and deployment of leading-edge
products for various fields and applications.
--- TRIPLE-1 “KAMIKAZE” Product Features:
1. Adopts the world's most advanced 7nm process technology
Develops
the world's first "KAMIKAZE", an ASIC (application specific IC) for
bitcoin mining with using world's Leading-Edge company TSMC (Taiwan) ’s
7nm process technology and evaluates the first tape out (first
generation) version, Power Efficiency: 52 J / TH was realized (measured
on September 26, 2018).
2. Reduced energy consumption that contributes to energy resource
conservation
By operating at ultra-low voltage (0.3V or less)
and achieving low power consumption, it is possible to contribute to the
reduction of the enormous power required for mining and energy resource
conservation while maintaining a high performance.
3. High cooling efficiency from changes in packaging
In
order to achieve higher cooling efficiency, we adopted a structure
(exposed die - FCBGA) in which the backside of the silicon chip is
exposed on the package to achieve higher cooling efficiency, chip size
was encapsulated in 7 mm × 7 mm.
--- TRIPLE-1 outline:
Company Name: TRIPLE-1, Inc.
Corporate Headquarter:
7F IT
Bldg.Ⅱ,1-14-20 Hakataeki-Higashi, Hakata-ku Fukuoka-shi, Fukuoka, Japan
Representatives:
Representative Director CEO Takuya Yamaguchi
The capital: 3662
million 895 thousand and 398 yen (including the capital reserve)
--- Features of Fujitsu Electronics:
As an "Electronics General Trading Company" that contributes to the development of customers' businesses through offering an extensive lineup of Fujitsu brand products centered on LSIs with leading-edge technology and proprietary products, as well as domestic and overseas manufacturer products, with comprehensive support including sales, technology, solution services, logistic services and more. With 13 locations in Japan and 20 locations overseas, we have established a global distributor system that can propose a wide range of solutions, building a consistent network that can respond to customer requests in a timely manner, from product procurement to development and mass production.
--- Fujitsu Electronics outline:
Company Name: Fujitsu Electronics Inc.
Corporate Headquarter:
2-100-45,
Shin-Yokohama, Kohoku-Ku, Yokohama-shi, Kanagawa, Japan
Representatives:
President and Representative Director Junji Ogihara
The capital:
4,877,683,581 yen
Website: http://www.fujitsu.com/jp/fei/en/
--- About the trademark:
Proper nouns such as the product names listed are trademarks or registered trademarks of their respective owners.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190318005034/en/
Contact:
Regarding this Press Release: TRIPLE-1, Inc. Public Relations Office GAKU MATSUSHIMA info@triple-1.com
Regarding Sales and Products: Fujitsu Electronics Inc. fei-triple1@dl.jp.fujitsu.com
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
First Randomized Controlled Trial Shows Promise of a Ketogenic Diet in Psychotic Disorders8.7.2026 15:00:00 CEST | Press release
Trial reports correlations between ketone levels and cognitive and psychiatric symptoms in individuals with schizophrenia-spectrum and bipolar-1 disorders Published today in Schizophrenia Bulletin, a first-of-its-kind randomized controlled trial (RCT) from researchers at the University of California, San Francisco (UCSF), and funded in part by the National Institute of Mental Health (NIMH), adds to growing literature on the potential benefit of a ketogenic diet for treating psychotic disorders. The study, which enrolled participants with schizophrenia-spectrum or bipolar-1 disorders, demonstrated rapid metabolic improvements with a ketogenic diet compared to diet-as-usual during an initial one-month RCT open-label phase. Furthermore, those who continued with the optional four-month single-arm ketogenic diet extension saw meaningful gains across metabolic, psychiatric, and cognitive measures. This press release features multimedia. View the full release here: https://www.businesswire.co
Teamily AI Publicly Launches Human+AI Social Platform to Make Building and Growing a Company Easy for Every Team8.7.2026 15:00:00 CEST | Press release
Teamily AI (https://Teamily.ai), together with its Agentic AI Infra platform TensorOpera AI (https://TensorOpera.ai), today announced the public launch of its Human+AI social platform, a product stack that has already served more than 5 million users around the world. Starting today in Palo Alto and rolling out simultaneously across dozens of countries, this first public launch opens the full stack to everyone with a single mission: to make building and growing a company easy for every person and every team. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260708584390/en/ "This is the moment we open our doors to the world," said co-founders Dr. Aiden Chaoyang He and Professor Salman Avestimehr. "We want every person and every team to be able to move from idea to product, from product to market, and from market to growth and investment, with an AI-native team by their side." At its core, Teamily AI enables humans and AI agents
Leo Cancer Care Raises $65M Series D to Scale Its Integrated Upright Cancer Care Platform8.7.2026 14:30:00 CEST | Press release
Oversubscribed round follows the world-first compact upright proton treatment at Stanford Medicine — funding a single upright platform that will span imaging and treatment across multiple radiation modalities. Leo Cancer Care, the medical technology company working to reinvent how patients are imaged and treated by designing systems around the body’s natural upright position, today announced the close of an oversubscribed $65 million Series D financing. The round was led by Silicon Valley’s Yu Galaxy and welcomes new investors including Eventide Asset Management, alongside continued support from the company’s existing investors. Leading cancer institutions are already adopting the upright approach. Stanford Medicine delivered the world’s first compact upright proton therapy treatment on 4 June 2026. Dana-Farber Cancer Institute and McLaren Health Care are among the institutions bringing the upright platform into their programmes — adoption that spans world-leading academic centers and
LUMI AI Factory Selects IQM to Deploy Advanced Quantum Computer, Accelerating Hybrid HPC and AI Development8.7.2026 14:00:00 CEST | Press release
The Halocene H4 quantum computer, named LUMI-IQ, will be delivered and installed in 2027 The system will be hosted at CSC – IT Center for Science in Finland and integrated into the LUMI AI Factory The system will provide researchers, industry innovators, and developers across Europe with a unique, advanced experimental platform where quantum computing and artificial intelligence converge The LUMI AI Factory, led by CSC – IT Center for Science, has selected IQM Quantum Computers (Nasdaq: IQMX) to deliver IQM Halocene H4, an advanced quantum computer aimed at accelerating hybrid high-performance computing, artificial intelligence, and quantum computing capabilities. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260708006791/en/ LUMI AI Factory selects IQM to deploy advanced quantum computer, accelerating hybrid HPC and AI development IQM Halocene H4 is the first and most advanced on-premises superconducting quantum computer o
Merck Announces FDA Breakthrough Therapy Designation for Enpatoran in Lupus Patients With Active Skin Manifestations8.7.2026 14:00:00 CEST | Press release
Enpatoran could address a significant unmet need in lupus, specifically targeting cutaneous manifestations of the disease, which currently have no approved therapiesFDA's decision was supported by Phase 2 WILLOW study results, which demonstrated meaningful symptoms improvement, particularly among patients with active cutaneous manifestationsEnpatoran's potential to go beyond current treatment standards in lupus prompted FDA´s breakthrough designation, which is designed to expedite drug development and reviewNot intended for Canada-, UK- or US-based media Merck, a leading science and technology company, today announced that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to enpatoran for the treatment of lupus with active cutaneous manifestations. Enpatoran is an oral selective toll-like receptor (TLR) 7/8 inhibitor, designed to modulate pathways central to lupus-related inflammation. “For the 85% of lupus patients whose disease includes skin manif
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
